RheumaGen at Fitzsimons Innovation to test promising gene therapy for rheumatoid arthritis

It was at the Clinimmune (a nonprofit biotech company in CU's Department of Medicine) lab at the University of Colorado Anschutz Medical Campus where scientists discovered they could edit a gene to make it resistant to auto-immune disease.

Brian Freed, PhD F(ACHI), the Executive Director of ClinImmune Cell and Gene Therapy (and professor of medicine), said, "So it's really like plastic surgery on the immune system."